amifostine anhydrous has been researched along with Proteinuria in 1 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
Proteinuria: The presence of proteins in the urine, an indicator of KIDNEY DISEASES.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rolleman, EJ | 1 |
| Forrer, F | 1 |
| Bernard, B | 1 |
| Bijster, M | 1 |
| Vermeij, M | 1 |
| Valkema, R | 1 |
| Krenning, EP | 1 |
| de Jong, M | 1 |
1 other study available for amifostine anhydrous and Proteinuria
| Article | Year |
|---|---|
Amifostine protects rat kidneys during peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotate.
Topics: Amifostine; Animals; Body Weight; Creatinine; Kidney; Lysine; Male; Neoplasms; Octreotide; Organomet | 2007 |